To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 October 2018 to Question 173542 on Allergies: Medical Treatments, what support his Department has provided to people affected by the national shortage of EpiPen 0.3mg auto-injectors.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 October 2018 to Question 173542 on Allergies: Medical Treatments, what assessment he has made of the effect of the national shortage of EpiPen 0.3mg Auto-Injectors on levels of supply of alternative epinephrine auto-injectors.
The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Health products Regulatory Agency, and NHS England to improve the situation as quickly as possible. Supplies of EpiPen 0.3mg and the alternative adrenaline auto-injectors are currently available in volumes that are sufficient to meet normal United Kingdom requirements and further deliveries of all three brands of adrenaline autoinjectors are expected in the coming weeks. Comprehensive information and guidance, with input from National Health Service allergy experts has been cascaded to all healthcare professionals, schools, patient groups and frontline NHS services, which provides information about the supply issue, management options and advice to share with patients.